The Chase Group Continues Successful Collaboration with Isis Pharmaceuticals

The Chase Group Continues Successful Collaboration with Isis Pharmaceuticals

The Chase Group announces the recruitment of Dr. Fred Derosier as Executive Director, Clinical Development. Dr. Derosier is excited to join such a dynamic organization, and TCG appreciates the opportunity to work together with Isis to expand their team of top-performing clinical development professionals.